Vivo Capital’s RayzeBio, Inc. Common Stock RYZB Stock Holding History

Vivo Capital’s Portfolio RYZB Stock Details RYZB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-110,581	Closed	-$6.87M	–	48
2023 Q4	$6.87M	Sell	110,581 -522,995	-83%	-$13M	0.56%	32
2023 Q3	$14.1M	Buy	+633,576	New	+$13.3M	1.54%	17

Vivo Capital's RYZB Position: Q1 2024 in Review

Vivo Capital sold out of RayzeBio, Inc. Common Stock (RYZB) in Q1 2024, closing a stake of 110,581 shares — an estimated $6.87M sold.

Vivo Capital first reported a position in RYZB in Q3 2023 and held it in 2 quarters. The position peaked at $14.1M in Q3 2023. 0 funds tracked by Wall St. Rank hold RYZB as of Q1 2024.

Vivo Capital reported no remaining RayzeBio, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
Vivo Capital sold 110,581 RayzeBio, Inc. Common Stock shares in Q1 2024, an estimated $6.87M.
Vivo Capital first reported a position in RayzeBio, Inc. Common Stock in Q3 2023 and held it in 2 quarters.
Vivo Capital's RayzeBio, Inc. Common Stock position peaked at $14.1M in Q3 2023.
0 funds tracked by Wall St. Rank held RayzeBio, Inc. Common Stock as of Q1 2024.

Based on Vivo Capital's 13F filing for Q1 2024, filed 22 Apr 2024.